BROWSE·page 93 of 1395

Browse EX-10 agreements

16,739 total material contract exhibits.


EX-10.1

USANA HEALTH SCIENCES INC

EXECUTION VERSION

FIRST AMENDMENT

THIS FIRST AMENDMENT (this “Amendment”), dated as of September 30, 2026 (the “First Amendment Effective Date”), is entered into among USANA HEALTH SCIENCES, INC., a Utah corporation (the “Borrower”), the other Guarantors party hereto, the Lenders party hereto, and Bank of America, N.A., as Administrative Agent (in such capacity, the “Administrative Agent”), Swingline Lender and L/C Issuer.

RECITALS

WHEREAS, the Borrower, the Guarantors from time to time party thereto, the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative Agent, Swingline Lender and L/C Issuer are parties to that certain Third Amended and Restated Credit Agreement, dated as of June 27, 2025 (as amended, modified, supplemented, increased, extended, restated, renewed, refinanced and replaced from time to time, the “Credit Agreement”);

WHEREAS, the Loan Parties have requested certain modifications to the Credit Agreement and the Required Lenders have agreed to such modifications on the terms and conditions herein.

…

EX-10.1·8-K·CIK 896264·ACC 0000896264-26-000060·Filed Oct 05, 2026, 16:36 ET

EX-10.1

Lycia Therapeutics, Inc.

FORM OF INDEMNITY AGREEMENT

This Indemnity Agreement, dated as of _____________, 2026 is made by and between Lycia Therapeutics, Inc., a Delaware corporation (the “Company”), and _____________________, a director, officer or key employee of the Company or one of the Company’s Subsidiaries or Affiliates (as those terms are defined below) or other service provider who satisfies the definition of Indemnifiable Person set forth below (“Indemnitee”).

RECITALS

A.    The Company is aware that competent and experienced persons are increasingly reluctant to serve as representatives of corporations unless they are protected by comprehensive liability insurance and indemnification, due to increased exposure to litigation costs and risks resulting from their service to such corporations, and due to the fact that the exposure frequently bears no relationship to the compensation of such representatives;

…

EX-10.1·S-1·CIK 1806540·ACC 0001628280-26-064973·Filed Oct 05, 2026, 16:36 ET

EX-10.9

Lycia Therapeutics, Inc.

LEASE AGREEMENT

THIS LEASE AGREEMENT (this “Lease”) is made this 3rd day of June, 2021, between ARE-EAST JAMIE COURT, LLC, a Delaware limited liability company (“Landlord”), and LYCIA THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

Building: 400 East Jamie Court, South San Francisco, California

…

EX-10.9·S-1·CIK 1806540·ACC 0001628280-26-064973·Filed Oct 05, 2026, 16:36 ET

EX-10.6

Lycia Therapeutics, Inc.

LYCIA THERAPEUTICS, INC.

EXECUTIVE SEVERANCE AND CHANGE IN CONTROL PLAN

This Executive Severance and Change in Control Plan (this “Plan”) was adopted by the Board of Directors (the “Board”) of Lycia Therapeutics, Inc., a Delaware corporation (the “Company”) and is effective on the Effective Date. Unless otherwise indicated, capitalized terms used in this Plan are defined in Section 5below.

1.Eligibility.

The following Company employees are eligible to participate in this Plan (each, an “Executive”):

…

EX-10.6·S-1·CIK 1806540·ACC 0001628280-26-064973·Filed Oct 05, 2026, 16:36 ET

EX-10.8

Lycia Therapeutics, Inc.

CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT LYCIA THERAPEUTICS, INC. TREATS AS PRIVATE OR CONFIDENTIAL.

LICENSE AGREEMENT

THIS LICENSE AGREEMENT (this “Agreement”) dated as of July 1, 2025 (the “Effective Date”), is entered into between Lycia Therapeutics, Inc., a Delaware corporation with an address at 400 East Jamie Ct., Suite 200, South San Francisco, CA 94080 (“Lycia”) and RSR Limited, a company incorporated in England and Wales with company number 03766047 and an address at Pare Ty Glas, Llanishen, Cardiff, CF14 5DU, UK (“RSR”). The parties agree as follows:

1.    DEFINITIONS. For purposes of this Agreement, the terms defined in this Section 1 shall have the respective meanings set forth below:

…

EX-10.8·S-1·CIK 1806540·ACC 0001628280-26-064973·Filed Oct 05, 2026, 16:36 ET

EX-10.2

Lycia Therapeutics, Inc.

LYCIA THERAPEUTICS, INC.

2020 EQUITY INCENTIVE PLAN

As Adopted on March 3, 2020

As Amended on June 30, 2020

As Amended on August 6, 2020

As Amended on September 30, 2020

As Amended on August 31, 2021

As Amended on December 9, 2021

As Amended on April 26, 2024

As Amended on June 9, 2026

1.    General.

(a)    Eligible Stock Award Recipients. Employees, Directors and Consultants are eligible to receive Stock Awards.

(b)    Available Stock Awards. The Plan provides for the grant of the following types of Stock Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights, (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards and (vi) Other Stock Awards.

(c)    Purpose. The Plan, through the grant of Stock Awards, is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and provide a means by which the eligible recipients may benefit from increases in value of the Common Stock.

…

EX-10.2·S-1·CIK 1806540·ACC 0001628280-26-064973·Filed Oct 05, 2026, 16:36 ET

Execution Version

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of October 1, 2026, between NN, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Rule 506 of Regulation D thereunder as to the Shares of Common Stock, and Pre-Funded Warrants (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

…

EX-10.1·8-K·CIK 918541·ACC 0000918541-26-000105·Filed Oct 05, 2026, 16:32 ET

Execution Version

REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into as of October 1, 2026, between NN, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

The Company and each Purchaser hereby agrees as follows:

1. Definitions.

Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.As used in this Agreement, the following terms shall have the following meanings:

“Advice” shall have the meaning set forth in Section 6(c).

…

EX-10.2·8-K·CIK 918541·ACC 0000918541-26-000105·Filed Oct 05, 2026, 16:32 ET

EX-10.2

Grayscale Hyperliquid Staking ETF

Certain confidential information contained in this document, marked by [***], has been omitted because the registrant has determined that the information (i) is not material and (ii) is the type that the registrant treats as private or confidential.

AMENDMENT NUMBER 2 TO AMENDED AND RESTATED BITGO CUSTODIAL SERVICES AGREEMENT AND MUTUAL TERMINATION OF CUSTODIAL SERVICES AGREEMENT (GRAYSCALE BITTENSOR TRUST (TAO))

This Amendment and Mutual Termination (this “Amendment”) to the Agreement (as defined below) is made and entered into as of the date last signed below (the “Amendment Effective Date”) by and between BitGo Bank & Trust, National Association (“Custodian”) and Grayscale Investments Sponsors, LLC, on behalf of each entity listed on Schedule B (collectively, “Client”). Custodian and Client are each a “Party” and together, the “Parties”.

…

EX-10.2·8-K·CIK 2107730·ACC 0001193125-26-414237·Filed Oct 05, 2026, 16:32 ET

EX-10.1

Grayscale Hyperliquid Staking ETF

Certain confidential information contained in this document, marked by [***], has been omitted because the registrant has determined that the information (i) is not material and (ii) is the type that the registrant treats as private or confidential.

AMENDED AND RESTATED BITGO CUSTODIAL SERVICES AGREEMENT

This Amended and Restated Custodial Services Agreement (this “Agreement”) is made as of June 5, 2026 (the “Effective Date”) by and between each entity listed on Schedule B (severally and not jointly, each a “Client”) and BitGo Bank & Trust, National Association (“Custodian”). This Agreement amends and restates the prior Custodial Services Agreement, effective May 15, 2025, between each Client and Custodian. This Agreement governs Client’s use of the Custodial Services and the Wallet Services (each as defined below, and collectively, the “Services”) provided or made available by Custodian.

…

EX-10.1·8-K·CIK 2107730·ACC 0001193125-26-414237·Filed Oct 05, 2026, 16:32 ET

EX-10.1

GENERATION INCOME PROPERTIES, INC.

FIRST AMENDMENT TO AMENDED AND RESTATED SECURED PROMISSORY NOTE

THIS FIRST AMENDMENT TO AMENDED AND RESTATED SECURED PROMISSORY NOTE (this “Amendment”) is entered into by Generation Income Properties, L.P., a Delaware limited partnership (the “Maker”), and Brown Family Enterprises LLC, a Delaware limited liability company (the “Noteholder”), effective as of October 14, 2026.

The Maker issued to the Noteholder an Amended and Restated Secured Promissory Note dated July 21, 2023, in the original principal amount of $5,500,000 (the “Note”), secured by the Amended and Restated Security Agreement dated July 21, 2023, between the Maker and the Noteholder (the “Security Agreement”). The Parties agree as follows:

1. PRINCIPAL BALANCE.The Parties acknowledge the Maker’s $300,000 principal payment on July 6, 2026, and confirm that the outstanding principal balance of the Note as of September 28, 2026, was $5,200,000. Any subsequent payments shall be credited in accordance with the Note. This acknowledgment does not capitalize interest or increase the indebtedness.

…

EX-10.1·8-K·CIK 1651721·ACC 0001193125-26-414221·Filed Oct 05, 2026, 16:30 ET